INSP

Inspire Medical Systems, Inc.

HALAL

Score: 87/100

stock

Is INSP Halal?

Manufacturer of an implantable neurostimulation medical-device system for obstructive sleep apnea — a permissible medical-device business with a strong, net-cash financial-screen profile.

What You Should Know

Inspire Medical Systems, Inc. is a publicly-traded medical-technology company focused on the development and commercialization of minimally-invasive solutions for patients with obstructive sleep apnea (OSA). Its core product is the Inspire system, an implantable neurostimulation device that delivers hypoglossal-nerve stimulation to maintain an open airway during sleep, together with the surgical-implant components, patient remote, and physician-and-patient support technology. Medical-device manufacturing, implantable-neurostimulation-system development, and the associated patient-therapy activities are general-purpose healthcare and medical-device activities that are unambiguously permissible — and indeed beneficial — at the activity level under standard Sharia methodology. The financial screen passes comfortably: Inspire operates a debt-free, net-cash balance sheet with a large cash-and-investments position and is generating positive free cash flow, and the debt-to-market-cap ratio sits effectively at zero, well below the 33% Sharia threshold. Most major Sharia advisory boards classify Inspire as permissible with purification of small interest-income components.

⚠️ Concerns

•Minor interest income on a large cash-and-investments balance — purification of a small portion of any future dividends may be advisable; Inspire operates a debt-free, net-cash balance sheet, so interest income is the principal financial-screen consideration. Note that with a sizable investment portfolio, the interest-income-to-revenue ratio should be checked against the 5% threshold and that the portfolio is invested in Sharia-acceptable instruments
•The medical-device business depends on reimbursement, regulatory clearances, and physician-adoption — these are business and regulatory considerations rather than Sharia screen concerns
•Inspire faces emerging competition (including from new entrants and from pharmaceutical OSA-and-weight-loss therapies) that could affect growth — this is a business-competition consideration rather than a Sharia screen concern
•Revenue is concentrated in a single product line and therapy area — this is a business-concentration consideration rather than a Sharia screen concern
•The stock frequently trades at a premium growth valuation and can be volatile — this is a valuation consideration rather than a Sharia screen concern
•Receivables-to-assets ratio should be checked against the preferred board's threshold at the time of investment